Early-phase development of cancer prevention agents: challenges and opportunities

about

Cancer Prevention: Obstacles, Challenges and the Road Ahead.Antioxidants meet molecular targets for cancer prevention and therapeutics.

P2860

Q37002946-DB28630D-3946-4EA2-9AA8-4B3148C25322 Q43119541-C8FE7572-367C-4B14-A513-25085211D640

P2860

Early-phase development of cancer prevention agents: challenges and opportunities

Item

http://www.wikidata.org/entity/Q36853927

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Early-phase development of cancer prevention agents: challenges and opportunities

@en

type

Item

label

Early-phase development of cancer prevention agents: challenges and opportunities

@en

prefLabel

Early-phase development of cancer prevention agents: challenges and opportunities

@en

P1476

Early-phase development of cancer prevention agents: challenges and opportunities

@en

P2093

Marjorie Perloff

http://www.w3.org/2001/XMLSchema#string

Vernon E Steele

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

Phase 0 trials: expediting the development of chemoprevention agents.

Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies.

Designing phase 0 cancer clinical trials.

Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials.

Phase 0 trials: an industry perspective.

Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies.

Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.

Phase 0 clinical trials: an answer to drug development stagnation?

Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing.

P304

379-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-12-0463

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23466485

http://www.w3.org/2001/XMLSchema#string

P932

3657502

http://www.w3.org/2001/XMLSchema#string

Early-phase development of cancer prevention agents: challenges and opportunities

about

P2860

P2860

Early-phase development of cancer prevention agents: challenges and opportunities

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932